Bristol Myers Squibb completes acquisition of Mirati Therapeutics...

Bristol Myers Squibb completes acquisition of Mirati Therapeutics

We announced that we completed our acquisition of Mirati Therapeutics – an important milestone as we continue to strengthen and diversify our oncology portfolio. Together, we will build on our long legacy of pioneering innovations in cancer treatments to transform the lives of patients.

Bristol Myers Squibb completes acquisition of Mirati Therapeutics

We announced that we completed our acquisition of Mirati Therapeutics – an important milestone as we continue to strengthen and diversify our oncology portfolio. Together, we will build on our long legacy of pioneering innovations in cancer treatments to transform the lives of patients.

Bristol Myers Squibb completes acquisition of Mirati Therapeutics

We announced that we completed our acquisition of Mirati Therapeutics – an important milestone as we continue to strengthen and diversify our oncology portfolio. Together, we will build on our long legacy of pioneering innovations in cancer treatments to transform the lives of patients.

Bristol Myers Squibb completes acquisition of Mirati Therapeutics

We announced that we completed our acquisition of Mirati Therapeutics – an important milestone as we continue to strengthen and diversify our oncology portfolio. Together, we will build on our long legacy of pioneering innovations in cancer treatments to transform the lives of patients.

Explore BMS

<h3> Doing R&D “differently” to transform treatment for serious diseases →

<h4 > PharmD resident takes journey of a lifetime >

Clinical Trials, Collaboration

Doing R&D “differently” to transform treatment for serious diseases →

< h4 >Complexity of cancer >

<h5>Untangling the complexity of cancer

< h4 >Using a multimodal toolbox to advance the next generation of cancer treatment >



2021 GLOBAL INCLUSION & DIVERSITY

Leading with our Value of Inclusion

 

Moving forward. Together.

 
 

Survivorship Today

Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.

Careers

We’re looking for people who want to change lives.  Join us as we transform patients’ lives through science. 

Investors

Learn more about how we strive to produce sustained strong performance and shareholder value.

Video Caption


 

Looking for answers?

 
 

Quick links to helpful resources.

 

Clinical Trial Information for researchers - RHEL Test

Clinical trials and research are a critical part of bringing new medicines to patients.

rtrytrytry

rtytrytrytry


Medical Information for healthcare providers

Information and resources to assist with caring for patients.

Help paying for your medicines

If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.

Unable to submit the form, please retry. Sorry for the inconvenience.

Please enter the correct format

Unable to submit the form, please retry. Sorry for the inconvenience.


  • test
  • test
  • test
  •  

Survivorship Today

Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.

Survivorship Today

Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.

Survivorship Today

Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.